PTPA and neoplasm: As a therapeutic strategy, inhibition of PP2A enhances the sensitization of cells to immunotherapy and treatment of autoimmune diseases and cancer, while tumor suppressive functions of PP2A is boosted by exploiting PP2A-activating strategies [116].